SEARCH

SEARCH BY CITATION

References

  • Bresalier, R.S., Rockwell, R.W., Dahiya, R., Duh, Q.Y. & Kim, Y.S. (1990) Cell surface sialoprotein alterations in metastatic murine colon cancer cell lines selected in an animal model for colon cancer metastasis. Cancer Res. 50, 12991307.
  • Christie, D.R., Shaikh, F.M., Lucas, J.A.T., Lucas, J.A. III & Bellis, S.L. (2008) ST6Gal-I expression in ovarian cancer cells promotes an invasive phenotype by altering integrin glycosylation and function. J. Ovarian Res. 1, 3.
  • Dall'Olio, F. (2000) The sialyl-alpha2,6-lactosaminyl-structure: biosynthesis and functional role. Glycoconj. J. 17, 669676.
  • Dall'Olio, F., Malagolini, N., di Stefano, G., Minni, F., Marrano, D. & Serafini-Cessi, F. (1989) Increased CMP-NeuAc:Gal beta 1,4GlcNAc-R alpha 2,6 sialyltransferase activity in human colorectal cancer tissues. Int. J. Cancer 44, 434439.
  • Fry, S.A., Afrough, B., Lomax-Browne, H.J., Timms, J.F., Velentzis, L.S. & Leathem, A.J. (2011) Lectin microarray profiling of metastatic breast cancers. Glycobiology 21, 10601070.
  • Fukushima, K., Hara-Kuge, S., Seko, A., Ikehara, Y. & Yamashita, K. (1998) Elevation of alpha2–>6 sialyltransferase and alpha1–>2 fucosyltransferase activities in human choriocarcinoma. Cancer Res. 58, 43014306.
  • Gessner, P., Riedl, S., Quentmaier, A. & Kemmner, W. (1993) Enhanced activity of CMP-neuAc:Gal beta 1-4GlcNAc:alpha 2,6-sialyltransferase in metastasizing human colorectal tumor tissue and serum of tumor patients. Cancer Lett. 75, 143149.
  • Gretschel, S., Haensch, W., Schlag, P.M. & Kemmner, W. (2003) Clinical relevance of sialyltransferases ST6GAL-I and ST3GAL-III in gastric cancer. Oncology 65, 139145.
  • Hakomori, S. (2002) Glycosylation defining cancer malignancy: new wine in an old bottle. Proc. Natl Acad. Sci. USA 99, 1023110233.
  • Haltiwanger, R.S. (2009) Fucose is on the TRAIL of colon cancer. Gastroenterology 137, 3639.
  • Harvey, B.E., Toth, C.A., Wagner, H.E., Steele, G.D. Jr & Thomas, P. (1992) Sialyltransferase activity and hepatic tumor growth in a nude mouse model of colorectal cancer metastases. Cancer Res. 52, 17751779.
  • Hedlund, M., Ng, E., Varki, A. & Varki, N.M. (2008) alpha 2-6-Linked sialic acids on N-glycans modulate carcinoma differentiation in vivo. Cancer Res. 68, 388394.
  • Iwamori, M., Iwamori, Y., Kubushiro, K., Ishiwata, I. & Kiguchi, K. (2007) Characteristic expression of Lewis-antigenic glycolipids in human ovarian carcinoma-derived cells with anticancer drug-resistance. J. Biochem. 141, 309317.
  • Kaneko, M., Nishihara, S., Shinya, N., Kudo, T., Iwasaki, H., Seno, T., Okubo, Y. & Narimatsu, H. (1997) Wide variety of point mutations in the H gene of Bombay and para-Bombay individuals that inactivate H enzyme. Blood 90, 839849.
  • Kaneko, Y., Yamamoto, H., Kersey, D.S., Colley, K.J., Leestma, J.E. & Moskal, J.R. (1996) The expression of Gal beta 1,4GlcNAc alpha 2,6 sialyltransferase and alpha 2,6-linked sialoglycoconjugates in human brain tumors. Acta Neuropathol. 91, 284292.
  • Kiguchi, K., Iwamori, Y., Suzuki, N., Kobayashi, Y., Ishizuka, B., Ishiwata, I., Kita, T., Kikuchi, Y. & Iwamori, M. (2006) Characteristic expression of globotriaosyl ceramide in human ovarian carcinoma-derived cells with anticancer drug resistance. Cancer Sci. 97, 13211326.
  • Kudo, T., Iwasaki, H., Nishihara, S., Shinya, N., Ando, T., Narimatsu, I. & Narimatsu, H. (1996) Molecular genetic analysis of the human Lewis histo-blood group system. II. Secretor gene inactivation by a novel single missense mutation A385T in Japanese nonsecretor individuals. J. Biol. Chem. 271, 98309837.
  • Kuno, A., Itakura, Y., Toyoda, M., Takahashi, Y., Yamada, Y., Umezawa, A. & Hirabayashi, J. (2008) Development of a data-mining system for differential profiling of cell glycoproteins based on lectin microarray. J. Proteomics Bioinform. 1, 068072.
  • Kuno, A., Matsuda, A., Ikehara, Y., Narimatsu, H. & Hirabayashi, J. (2010) Differential glycan profiling by lectin microarray targeting tissue specimens. Methods Enzymol. 478, 165179.
  • Kuno, A., Uchiyama, N., Koseki-Kuno, S., Ebe, Y., Takashima, S., Yamada, M. & Hirabayashi, J. (2005) Evanescent-field fluorescence-assisted lectin microarray: a new strategy for glycan profiling. Nat. Methods 2, 851856.
  • Le Marer, N. & Stehelin, D. (1995) High alpha-2,6-sialylation of N-acetyllactosamine sequences in ras-transformed rat fibroblasts correlates with high invasive potential. Glycobiology 5, 219226.
  • Lin, S., Kemmner, W., Grigull, S. & Schlag, P.M. (2002) Cell surface alpha 2,6 sialylation affects adhesion of breast carcinoma cells. Exp. Cell Res. 276, 101110.
  • Lise, M., Belluco, C., Perera, S.P., Patel, R., Thomas, P. & Ganguly, A. (2000) Clinical correlations of alpha2,6-sialyltransferase expression in colorectal cancer patients. Hybridoma 19, 281286.
  • Lopez-Morales, D., Velazquez-Marquez, N., Valenzuela, O., Santos-Lopez, G., Reyes-Leyva, J. & Vallejo-Ruiz, V. (2009) Enhanced sialyltransferases transcription in cervical intraepithelial neoplasia. Invest. Clin. 50, 4553.
  • Matsuda, A., Kuno, A., Ishida, H., Kawamoto, T., Shoda, J. & Hirabayashi, J. (2008) Development of an all-in-one technology for glycan profiling targeting formalin-embedded tissue sections. Biochem. Biophys. Res. Commun. 370, 259263.
  • Matsuda, A., Kuno, A., Kawamoto, T., Matsuzaki, H., Irimura, T., Ikehara, Y., Zen, Y., Nakanuma, Y., Yamamoto, M., Ohkohchi, N., Shoda, J., Hirabayashi, J. & Narimatsu, H. (2010) Wisteria floribunda agglutinin-positive mucin 1 is a sensitive biliary marker for human cholangiocarcinoma. Hepatology 52, 174182.
  • Miyoshi, E., Shinzaki, S., Moriwaki, K. & Matsumoto, H. (2010) Identification of fucosylated haptoglobin as a novel tumor marker for pancreatic cancer and its possible application for a clinical diagnostic test. Methods Enzymol. 478, 153164.
  • Mondal, S., Chandra, S. & Mandal, C. (2010) Elevated mRNA level of hST6Gal I and hST3Gal V positively correlates with the high risk of pediatric acute leukemia. Leuk. Res. 34, 463470.
  • Narimatsu, H., Sawaki, H., Kuno, A., Kaji, H., Ito, H. & Ikehara, Y. (2010) A strategy for discovery of cancer glyco-biomarkers in serum using newly developed technologies for glycoproteomics. FEBS J. 277, 95105.
  • Opdenakker, G., Rudd, P.M., Ponting, C.P. & Dwek, R.A. (1993) Concepts and principles of glycobiology. FASEB J. 7, 13301337.
  • Osumi, D., Takahashi, M., Miyoshi, E., Yokoe, S., Lee, S.H., Noda, K., Nakamori, S., Gu, J., Ikeda, Y., Kuroki, Y., Sengoku, K., Ishikawa, M. & Taniguchi, N. (2009) Core fucosylation of E-cadherin enhances cell-cell adhesion in human colon carcinoma WiDr cells. Cancer Sci. 100, 888895.
  • Petretti, T., Kemmner, W., Schulze, B. & Schlag, P.M. (2000) Altered mRNA expression of glycosyltransferases in human colorectal carcinomas and liver metastases. Gut 46, 359366.
  • Recchi, M.A., Harduin-Lepers, A., Boilly-Marer, Y., Verbert, A. & Delannoy, P. (1998) Multiplex RT-PCR method for the analysis of the expression of human sialyltransferases: application to breast cancer cells. Glycoconj. J. 15, 1927.
  • Sata, T., Roth, J., Zuber, C., Stamm, B. & Heitz, P.U. (1991) Expression of alpha 2,6-linked sialic acid residues in neoplastic but not in normal human colonic mucosa. A lectin-gold cytochemical study with Sambucus nigra and Maackia amurensis lectins. Am. J. Pathol. 139, 14351448.
  • Seales, E.C., Jurado, G.A., Brunson, B.A., Wakefield, J.K., Frost, A.R. & Bellis, S.L. (2005) Hypersialylation of beta1 integrins, observed in colon adenocarcinoma, may contribute to cancer progression by up-regulating cell motility. Cancer Res. 65, 46454652.
  • Shah, M.H., Telang, S.D., Shah, P.M. & Patel, P.S. (2008) Tissue and serum alpha 2-3- and alpha 2-6-linkage specific sialylation changes in oral carcinogenesis. Glycoconj. J. 25, 279290.
  • Shaikh, F.M., Seales, E.C., Clem, W.C., Hennessy, K.M., Zhuo, Y. & Bellis, S.L. (2008) Tumor cell migration and invasion are regulated by expression of variant integrin glycoforms. Exp. Cell Res. 314, 29412950.
  • Sharov, A.A., Dudekula, D.B. & Ko, M.S. (2005) A web-based tool for principal component and significance analysis of microarray data. Bioinformatics (Oxford, England) 21, 25482549.
  • Tateno, H., Toyota, M., Saito, S., Onuma, Y., Ito, Y., Hiemori, K., Fukumura, M., Matsushima, A., Nakanishi, M., Ohnuma, K., Akutsu, H., Umezawa, A., Horimoto, K., Hirabayashi, J. & Asashima, M. (2011) Glycome diagnosis of human induced pluripotent stem cells using lectin microarray. J. Biol. Chem. 286, 2034520353.
  • Toyoda, M., Yamazaki-Inoue, M., Itakura, Y., Kuno, A., Ogawa, T., Yamada, M., Akutsu, H., Takahashi, Y., Kanzaki, S., Narimatsu, H., Hirabayashi, J. & Umezawa, A. (2011) Lectin microarray analysis of pluripotent and multipotent stem cells. Genes Cells 16, 111.
  • Vanderschaeghe, D., Festjens, N., Delanghe, J. & Callewaert, N. (2010) Glycome profiling using modern glycomics technology: technical aspects and applications. Biol. Chem. 391, 149161.
  • Wang, P.H., Lee, W.L., Juang, C.M., Yang, Y.H., Lo, W.H., Lai, C.R., Hsieh, S.L. & Yuan, C.C. (2005) Altered mRNA expressions of sialyltransferases in ovarian cancers. Gynecol. Oncol. 99, 631639.
  • Yamamoto, K., Kikuchi, Y., Kudoh, K. & Nagata, I. (2000) Modulation of cisplatin sensitivity by taxol in cisplatin-sensitive and -resistant human ovarian carcinoma cell lines. J. Cancer Res. Clin. Oncol. 126, 168172.
  • Zhu, Y., Srivatana, U., Ullah, A., Gagneja, H., Berenson, C.S. & Lance, P. (2001) Suppression of a sialyltransferase by antisense DNA reduces invasiveness of human colon cancer cells in vitro. Biochim. Biophys. Acta 1536, 148160.